Sustainable Insight Capital Management LLC Sells 100 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sustainable Insight Capital Management LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.8% in the third quarter, Holdings Channel reports. The institutional investor owned 681 shares of the healthcare conglomerate’s stock after selling 100 shares during the quarter. Sustainable Insight Capital Management LLC’s holdings in UnitedHealth Group were worth $398,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in UNH. China Universal Asset Management Co. Ltd. increased its holdings in UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after acquiring an additional 1,857 shares during the period. Quent Capital LLC raised its position in shares of UnitedHealth Group by 5.5% in the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after buying an additional 217 shares in the last quarter. Reynders McVeigh Capital Management LLC increased its stake in UnitedHealth Group by 5.6% in the 1st quarter. Reynders McVeigh Capital Management LLC now owns 760 shares of the healthcare conglomerate’s stock worth $376,000 after acquiring an additional 40 shares during the last quarter. Choate Investment Advisors boosted its position in shares of UnitedHealth Group by 15.6% during the 1st quarter. Choate Investment Advisors now owns 26,644 shares of the healthcare conglomerate’s stock valued at $13,181,000 after acquiring an additional 3,592 shares during the last quarter. Finally, NorthRock Partners LLC raised its stake in UnitedHealth Group by 21.0% in the first quarter. NorthRock Partners LLC now owns 8,114 shares of the healthcare conglomerate’s stock valued at $4,014,000 after purchasing an additional 1,408 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $615.81 on Friday. The company has a 50 day moving average of $581.93 and a 200 day moving average of $545.03. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $619.80. The firm has a market cap of $566.72 billion, a P/E ratio of 40.12, a PEG ratio of 1.81 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $6.56 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. Cantor Fitzgerald increased their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Stephens dropped their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, Truist Financial reissued a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.